5.60
Schlusskurs vom Vortag:
$4.83
Offen:
$4.86
24-Stunden-Volumen:
250.75K
Relative Volume:
2.90
Marktkapitalisierung:
$15.86M
Einnahmen:
$755.00K
Nettoeinkommen (Verlust:
$-9.33M
KGV:
-0.9807
EPS:
-5.71
Netto-Cashflow:
$-5.43M
1W Leistung:
+23.89%
1M Leistung:
+114.56%
6M Leistung:
+24.44%
1J Leistung:
+68.47%
Mangoceuticals Inc Stock (MGRX) Company Profile
Firmenname
Mangoceuticals Inc
Sektor
Branche
Telefon
(833) 626-4679
Adresse
15110 DALLAS PKWY, SUITE 600, DALLAS
Vergleichen Sie MGRX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MGRX
Mangoceuticals Inc
|
5.60 | 15.86M | 755.00K | -9.33M | -5.43M | -5.71 |
![]()
VEEV
Veeva Systems Inc
|
229.19 | 37.21B | 2.66B | 665.91M | 1.08B | 4.05 |
![]()
DOCS
Doximity Inc
|
76.68 | 14.39B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
85.71 | 13.49B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
SOLV
Solventum Corp
|
73.98 | 12.78B | 8.26B | 66.00M | 1.17B | 0.3682 |
![]()
HQY
Healthequity Inc
|
113.78 | 9.86B | 1.15B | 96.70M | -161.99M | 1.09 |
Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten
Mangoceuticals Inc. issues stock for consulting services - Investing.com
Mangoceuticals (MGRX): A Low Float Stock on the Verge of a Short Squeeze? - Small Cap Exclusive
Mangoceuticals (NASDAQ:MGRX) versus Quipt Home Medical (NASDAQ:QIPT) Head to Head Analysis - Defense World
Mangoceuticals targets avian flu with water-based solution By Investing.com - Investing.com Nigeria
Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution - Marketscreener.com
Mangoceuticals Advances Research on Avian Flu Treatment for Poultry Industry - Defense World
Mangoceuticals targets avian flu with water-based solution - MSN
Mangoceuticals Advances Research On Avian Flu Solution For Poultry -February 12, 2025 at 08:19 am EST - Marketscreener.com
Mangoceuticals Advances Antiviral Research on its Patented - GlobeNewswire
Revolutionary Water-Based Solution Shows Promise in Fighting Bird Flu CrisisPhase I Results Reveal Major Breakthrough - StockTitan
Mangoceuticals Inc (MGRX) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Mangoceuticals (NASDAQ: MGRX): A High-Growth Play With Multiple Catalysts - Small Cap Exclusive
Mangoceuticals Expands COO Role and Increases Compensation - TipRanks
Mangoceuticals Advances H1N1 Efficacy Study Noting - GlobeNewswire
Mangoceuticals advances in H1N1 and H5N1 studies - Investing.com
Mangoceuticals advances in H1N1 and H5N1 studies By Investing.com - Investing.com UK
Major H1N1 Treatment Success: Mangoceuticals' Novel Antiviral Shows Promise Against Bird Flu - StockTitan
Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research - Business Upturn
Mangoceuticals executes exclusive distribution agreement with Propre - MSN
Mangoceuticals Signs Exclusive Distribution Deal With Propre Energie For Dermytol - Nasdaq
Mangoceuticals, Inc. Executes Exclusive Distribution - GlobeNewswire
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation - Marketscreener.com
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol Skincare Treatment Targeting Hyperpigmentation - Marketscreener.com
Mangoceuticals, Inc. Announces Closing of $5 Million Initial Public Offering - ACCESS Newswire
MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market - ACCESS Newswire
Mangoceuticals, Inc. Finalizes Debt Conversion and Appointments - TipRanks
Mangoceuticals alters stockholder rights, amends bylaws - MSN
Mangoceuticals alters stockholder rights, amends bylaws By Investing.com - Investing.com Canada
Mangoceuticals, Inc. announced that it has received $0.55 million in funding - Marketscreener.com
Mangoceuticals, Inc. announced that it has received $0.05 million in funding - Marketscreener.com
Mangoceuticals, Inc. announced that it has received $0.3 million in funding - Marketscreener.com
Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Investors - Defense World
Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Accredited Investors - Defense World
Patent Acquisition Fuels Mangoceuticals (MGRX) Stock Surge During Extended Trading - Stocks Telegraph
Mangoceuticals Shares Rise 22%, Company Acquires Mushroom-Based Wellness and Innovations Patent - MarketWatch
Mangoceuticals Expands with Patent Acquisition in Nutraceuticals - TipRanks
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent - GlobeNewswire
Mangoceuticals inks new service agreement, issues equity By Investing.com - Investing.com Nigeria
Mangoceuticals inks new service agreement, issues equity - Investing.com India
Mangoceuticals probes unusual stock activity post-split - Investing.com
Mangoceuticals initiates investigation into potential stock manipulation - TipRanks
Mangoceuticals probes unusual stock activity post-split By Investing.com - Investing.com UK
Mangoceuticals, Inc. Initiates Investigation into Potential - GlobeNewswire
MangoRx Launches Investigation Into Suspicious Trading Activity After Stock Split - StockTitan
Mangoceuticals Inc. (MGRX) Quarterly 10-Q Report - Quartzy
Mangoceuticals Signs Consulting Deal with CFO Johnston - TipRanks
Mangoceuticals (MGRX) versus Its Competitors Head-To-Head Contrast - Defense World
Financial Comparison: Mangoceuticals (MGRX) versus Its Competitors - Defense World
Mangoceuticals (MGRX) and The Competition Head-To-Head Comparison - Defense World
Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):